{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:54:00Z","timestamp":1785912840312,"version":"3.56.0"},"reference-count":77,"publisher":"Elsevier","isbn-type":[{"value":"9780443415470","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apha.2026.03.001","type":"book-chapter","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:19:52Z","timestamp":1777580392000},"page":"1-39","source":"Crossref","is-referenced-by-count":0,"title":["Toward non-invasive CNS delivery: The emergence of brain shuttle peptides"],"prefix":"10.1016","author":[{"given":"Macarena","family":"S\u00e1nchez-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00ed","family":"Oller-Salvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apha.2026.03.001_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","article-title":"Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics","volume":"330","author":"Akhtar","year":"2021","journal-title":"Journal of Controlled Release"},{"issue":"6","key":"10.1016\/bs.apha.2026.03.001_bib3","doi-asserted-by":"crossref","DOI":"10.1039\/D1RA08131D","article-title":"Homogeneous antibody-angiopep 2 conjugates for effective brain targeting","volume":"12","author":"Anami","year":"2022","journal-title":"RSC Advances"},{"key":"10.1016\/bs.apha.2026.03.001_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/bs.apha.2026.03.001_bib5","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric Nanoparticles for Drug Delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.apha.2026.03.001_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2017.04.006","article-title":"Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery","volume":"255","author":"Belhadj","year":"2017","journal-title":"Journal of Controlled Release"},{"issue":"26","key":"10.1016\/bs.apha.2026.03.001_bib7","doi-asserted-by":"crossref","first-page":"16359","DOI":"10.1021\/acsnano.4c01790","article-title":"Peptide-hitchhiking for the development of nanosystems in glioblastoma","volume":"18","author":"Branco","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12987-024-00545-5","article-title":"Molecular determinants for brain targeting by peptides: A meta-analysis approach with experimental validation","volume":"21","author":"Cavaco","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-025-02426-1","article-title":"Rapid amyloid-\u03b2 clearance and cognitive recovery through multivalent modulation of blood\u2013brain barrier transport","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"45","key":"10.1016\/bs.apha.2026.03.001_bib10","doi-asserted-by":"crossref","first-page":"41889","DOI":"10.1021\/acsami.9b14046","article-title":"Blood\u2013brain barrier- and blood\u2013brain tumor barrier-penetrating peptide-derived targeted therapeutics for glioma and malignant tumor brain metastases","volume":"11","author":"Chen","year":"2019","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"22","key":"10.1016\/bs.apha.2026.03.001_bib11","doi-asserted-by":"crossref","first-page":"14388","DOI":"10.1021\/acsnano.4c00994","article-title":"Organ-on-a-chip approach for accelerating blood\u2013brain barrier nanoshuttle discovery","volume":"18","author":"Choi","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ymthe.2022.11.015","article-title":"Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier","volume":"31","author":"Critchley","year":"2023","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib13","first-page":"1064","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2008","journal-title":"Pharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.001_bib14","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: An analysis for the global burden of disease study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"issue":"44","key":"10.1016\/bs.apha.2026.03.001_bib15","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1039\/C8SC02415D","article-title":"Branched BBB-shuttle peptides: Chemoselective modification of proteins to enhance blood-brain barrier transport","volume":"9","author":"D\u00edaz-Perlas","year":"2018","journal-title":"Chemical Science"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/bip.22928","article-title":"Phage display as a tool to discover blood\u2013brain barrier (BBB)-shuttle peptides: Panning against a human BBB cellular model","volume":"108","author":"D\u00edaz-Perlas","year":"2017","journal-title":"Biopolymers"},{"key":"10.1016\/bs.apha.2026.03.001_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood\u2013brain barrier transport: Advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Materials Today"},{"issue":"11","key":"10.1016\/bs.apha.2026.03.001_bib18","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","article-title":"Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier","volume":"88","author":"Friden","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2026.03.001_bib19","article-title":"Mechanisms of cellular uptake of cell-penetrating peptides","volume":"2011","author":"Futaki","year":"2011","journal-title":"Biophysical Journal"},{"key":"10.1016\/bs.apha.2026.03.001_bib20","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.2147\/IJN.S549893","article-title":"Nanotechnology for neurodegenerative diseases: Recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics","volume":"20","author":"Gao","year":"2025","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.apha.2026.03.001_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114362","article-title":"Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases","volume":"187","author":"Gao","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"8","key":"10.1016\/bs.apha.2026.03.001_bib22","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On the rate and extent of drug delivery to the brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharmaceutical Research"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.4049\/jimmunol.153.3.960","article-title":"Functional specialization of fibronectin-binding beta 1-integrins in T lymphocyte migration","volume":"153","author":"Hauzenberger","year":"1994","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/bs.apha.2026.03.001_bib24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"Vitro models of the blood\u2013brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/bs.apha.2026.03.001_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejpb.2019.04.004","article-title":"Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?","volume":"139","author":"Hu","year":"2019","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e. V"},{"issue":"12","key":"10.1016\/bs.apha.2026.03.001_bib26","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1021\/acs.molpharmaceut.6b00687","article-title":"Optimization and in vivo validation of peptide vectors targeting the LDL receptor","volume":"13","author":"Jacquot","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"16","key":"10.1016\/bs.apha.2026.03.001_bib27","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.3390\/ijms23169361","article-title":"Lipid Nanoparticles: Promising Treatment Approach for Parkinson\u2019s Disease","volume":"23","author":"Jagaran","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.apha.2026.03.001_bib28","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1021\/acsbiomaterials.3c01622","article-title":"RVG29 peptide-modified exosomes loaded with Mir-133b mediate the RhoA-ROCK pathway to improve motor and neurological symptoms in Parkinson\u2019s disease","volume":"10","author":"Jiang","year":"2024","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"545","key":"10.1016\/bs.apha.2026.03.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib30","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1038\/s41467-021-24323-1","article-title":"Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles","volume":"12","author":"Kucharz","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apha.2026.03.001_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.apha.2026.03.001_bib32","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1432-1327.2001.02073.x","article-title":"Receptor mediated uptake of peptides that bind the human transferrin receptor","volume":"268","author":"Lee","year":"2001","journal-title":"European Journal of Biochemistry \/ FEBS"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06544.x","article-title":"Macromolecular drug transport into the brain using targeted therapy","volume":"113","author":"Lichota","year":"2010","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"10.1016\/bs.apha.2026.03.001_bib34","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/pharmaceutics13122065","article-title":"Protease-resistant peptides for targeting and intracellular delivery of therapeutics","volume":"13","author":"Lucana","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/D3CB00194F","article-title":"BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium","volume":"5","author":"Lucana","year":"2023","journal-title":"RSC Chemical Biology"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s13346-025-01902-z","article-title":"Development of simplified poly(\u03b2-aminoester)-zwitterion nanovehicles for controlled cancer cell transfection and enhanced gene delivery across a cell-based model of the blood-brain barrier","volume":"16","author":"Lucana","year":"2025","journal-title":"Drug Delivery and Translational Research"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib37","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/acs.molpharmaceut.4c01091","article-title":"A site-specific MiniAp4\u2013trastuzumab conjugate prevents brain metastasis","volume":"22","author":"Masmudi-Mart\u00edn","year":"2025","journal-title":"Molecular Pharmaceutics"},{"issue":"5","key":"10.1016\/bs.apha.2026.03.001_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jnen\/nlz014","article-title":"Poly-arginine peptides R18 and R18D improve functional outcomes after endothelin-1-induced stroke in the sprague dawley rat","volume":"78","author":"Meloni","year":"2019","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/bs.apha.2026.03.001_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","author":"Muttenthaler","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.apha.2026.03.001_bib40","first-page":"927","article-title":"Drug targeting to brain: A systematic approach to study the factors","author":"Nagpal","year":"2013","journal-title":"Parameters and Approaches for Prediction of Permeability of Drugs across BBB"},{"key":"10.1016\/bs.apha.2026.03.001_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/bs.apha.2026.03.001_bib42","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Review development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2026.03.001_bib43","article-title":"From venoms to BBB shuttles","author":"Oller-salvia","year":"2013","journal-title":"Synthesis and Blood-Brain Barrier Transport Assessment of Apamin and a Non-Toxic Analog"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.001_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/anie.201508445","article-title":"MiniAp-4: A venom-inspired peptidomimetic for brain delivery","volume":"55","author":"Oller-Salvia","year":"2016","journal-title":"Angewandte Chemie - International Edition"},{"issue":"17","key":"10.1016\/bs.apha.2026.03.001_bib45","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: An emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/bs.apha.2026.03.001_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd725","article-title":"Drug and gene targeting to the brain with molecular trojan horses","volume":"1","author":"Pardridge","year":"2002","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/edrv-7-3-314","article-title":"Receptor-mediated peptide transport through the blood-brain barrier","volume":"7","author":"PARDRIDGE","year":"1986","journal-title":"Endocrine Reviews"},{"issue":"13","key":"10.1016\/bs.apha.2026.03.001_bib48","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1002\/anie.201411408","article-title":"Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier","volume":"54","author":"Prades","year":"2012","journal-title":"Angewandte Chemie - International Edition"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib49","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/acs.molpharmaceut.4c01327","article-title":"New trends in brain shuttle peptides","volume":"22","author":"Prades","year":"2025","journal-title":"Molecular Pharmaceutics"},{"issue":"March","key":"10.1016\/bs.apha.2026.03.001_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2017.03.037","article-title":"GRP78 enabled micelle-based glioma targeted drug delivery","volume":"255","author":"Ran","year":"2017","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1208\/s12248-008-9009-8","article-title":"Prodrug approaches for CNS delivery","volume":"10","author":"Rautio","year":"2008","journal-title":"The AAPS Journal"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/1535-7163.MCT-14-0399","article-title":"ANG4043, a novel brain-penetrant peptide-MAb conjugate, is efficacious against HER2-positive intracranial tumors in mice","volume":"14","author":"Regina","year":"2015","journal-title":"Molecular Cancer Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.001_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector angiopep-2","volume":"155","author":"R\u00e9gina","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2026.03.001_bib54","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.3390\/pharmaceutics14091874","article-title":"Peptide shuttles for blood\u2013brain barrier drug delivery","volume":"14","author":"S\u00e1nchez-Navarro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.03.001_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/164_2020_394","article-title":"Transport studies using blood-brain barrier in vitro models: A critical review and guidelines","author":"Santa-Maria","year":"2020","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"5433","key":"10.1016\/bs.apha.2026.03.001_bib56","first-page":"1569","article-title":"Vivo protein transduction: Delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science (1979)"},{"issue":"8","key":"10.1016\/bs.apha.2026.03.001_bib57","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/bioinformatics\/btaa918","article-title":"LightBBB: computational prediction model of blood\u2013brain-barrier penetration based on LightGBM","volume":"37","author":"Shaker","year":"2020","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/bs.apha.2026.03.001_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2025.5789","article-title":"Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (review)","volume":"67","author":"Si","year":"2025","journal-title":"International Journal of Oncology"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI44798","article-title":"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma","volume":"121","author":"Staquicini","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2026.03.001_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.101443","article-title":"Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma","volume":"30","author":"Sun","year":"2025","journal-title":"Materials Today Bio"},{"issue":"5","key":"10.1016\/bs.apha.2026.03.001_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac357","article-title":"A merged molecular representation deep learning method for blood\u2013brain barrier permeability prediction","volume":"23","author":"Tang","year":"2022","journal-title":"Briefings in Bioinformatics"},{"key":"10.1016\/bs.apha.2026.03.001_bib62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jconrel.2024.04.006","article-title":"A blood\u2013brain barrier- and blood\u2013brain tumor barrier-penetrating SiRNA delivery system targeting gliomas for brain tumor immunotherapy","volume":"369","author":"Tang","year":"2024","journal-title":"Journal of Controlled Release"},{"issue":"38","key":"10.1016\/bs.apha.2026.03.001_bib63","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1021\/ja073522o","article-title":"Diketopiperazines as a tool for the study of transport across the blood\u2212brain barrier (BBB) and their potential use as BBB-shuttles","volume":"129","author":"Teixid\u00f3","year":"2007","journal-title":"Journal of the American Chemical Society"},{"issue":"6","key":"10.1016\/bs.apha.2026.03.001_bib64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/bip.22275","article-title":"Dual system for the central nervous system targeting and blood-brain barrier transport of a selective prolyl oligopeptidase inhibitor","volume":"100","author":"Teixid\u00f3","year":"2013","journal-title":"Biopolymers"},{"issue":"5","key":"10.1016\/bs.apha.2026.03.001_bib65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood\u2013brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"48","key":"10.1016\/bs.apha.2026.03.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abc4397","article-title":"On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias","volume":"6","author":"Tian","year":"2020","journal-title":"Science Advances"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00429-011-0375-0","article-title":"Brainpeps: the blood\u2013brain barrier peptide database","volume":"217","author":"Van Dorpe","year":"2011","journal-title":"Brain Structure and Function"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.001_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2021.1904773","article-title":"Surface charge, glycocalyx, and blood-brain barrier function","volume":"9","author":"Walter","year":"2021","journal-title":"Tissue Barriers"},{"key":"10.1016\/bs.apha.2026.03.001_bib69","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jconrel.2019.11.005","article-title":"Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes","volume":"316","author":"Wang","year":"2019","journal-title":"Journal of Controlled Release"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.001_bib70","doi-asserted-by":"crossref","DOI":"10.1021\/mp500086e","article-title":"Retro-inverso isomer of angiopep-2: A stable D - peptide ligand inspires brain-targeted drug delivery","volume":"11","author":"Wei","year":"2014","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"9","key":"10.1016\/bs.apha.2026.03.001_bib72","doi-asserted-by":"crossref","DOI":"10.1021\/mp500393m","article-title":"Apamin-mediated actively targeted drug delivery for treatment of spinal cord injury: More than just a concept","volume":"11","author":"Wu","year":"2014","journal-title":"Molecular Pharmaceutics"},{"issue":"23","key":"10.1016\/bs.apha.2026.03.001_bib73","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1128\/JVI.74.23.11359-11366.2000","article-title":"Recombinant human adenovirus: Targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium","volume":"74","author":"Xia","year":"2000","journal-title":"Journal of Virology"},{"issue":"84","key":"10.1016\/bs.apha.2026.03.001_bib74","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Science Translational Medicine"},{"issue":"24","key":"10.1016\/bs.apha.2026.03.001_bib75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2021.05.044","article-title":"Multifunctional nanorods based on self-assembly of biomimetic apolipoprotein E peptide for the treatment of Alzheimer\u2019s disease","volume":"335","author":"Zhang","year":"2021","journal-title":"Journal of Controlled Release"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.001_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003937","article-title":"Development of Polymeric Nanoparticles for Blood\u2013Brain Barrier Transfer\u2014Strategies and Challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Advanced Science"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.001_bib77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","article-title":"Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies","volume":"89","author":"Zuchero","year":"2016","journal-title":"Neuron"}],"container-title":["Advances in Pharmacology","Brain Shuttle Peptides: Development and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:38:19Z","timestamp":1785911899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358926000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443415470"],"references-count":77,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2026.03.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}